Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 41INDUSTRY 10NETWORK 5NIH 3UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Paclitaxel 8nedaplatin 3TP protocol 3nimotuzumab 2S 1 (combination) 2Radiation 2Esophagectomy 2Cisplatin 2pegylated granulocyte colony-stimulating factor 1Radiotherapy, Adjuvant 1Platinum 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Neoplasms × Irinotecan × Clear all
NCT02319187 2015-08-03

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

ChineseAMS

Phase 3 Unknown
240 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡